Publications by authors named "K Beldjord"

Claim this Profile
to: Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Emilio Iannitto, Simone Ferrero, Côme Bommier, Daniela Drandi, Martina Ferrante, Kheira Beldjord

Haematologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Emilio Iannitto, Simone Ferrero, Côme Bommier, Daniela Drandi, Martina Ferrante, Kheira Beldjord

Haematologica· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New and Simple TRG Multiplex PCR Assay for Assessment of T-cell Clonality: A Comparative Study from the EuroClonality Consortium.
Marine Armand, Coralie Derrieux, Kheira Beldjord, Tamara Wabeke, Dido Lenze

Hemasphere· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study.
A Desjonquères, P Chevallier, X Thomas, F Huguet, T Leguay, K Beldjord

Blood Cancer J· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.
Sébastien Maury, Sylvie Chevret, Xavier Thomas, Dominik Heim, Thibaut Leguay, Kheira Beldjord

N Engl J Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis